Hepatitis C is curable in 90 to 100 percent of patients, according to the Food and Drug Administration. As of 2014, hepatitis C treatments include Olysio, Sovaldi and Victrelis. Some expensive, prescription medications can cure the disease as soon as 12 weeks after the regimen commences.
A 2014 Boston Globe article reports that since it came onto the market in December of 2013, Sovaldi’s cure rate has risen above 90 percent. The full treatment regimen takes a relatively short three months, compared to earlier treatments which lasted six months to a year. Sovaldi is a pill, which makes it easier for patients to take than the injections required for interferon treatment. This treatment also greatly reduces or eliminates the flu-like symptoms and fatigue associated with interferon. The Food and Drug Administration indicates that Sovaldi is sometimes used in conjunction with Olysio and Victrelis, which are both protease inhibitors that are still used in interferon regimens.
According to a June 2014 report by Reuters, Bristol-Myers Squibb plans to test Sovaldi with one of its antiviral drugs, in an attempt to reduce the treatment time down to four weeks. A shortened regimen can cut the almost $100,000 price of treatment by more than half. An October 2014 NPR report states that another approved treatment regimen, called Harvoni, takes 12 weeks, and it does not need to be taken with another drug.